Associations of Gestational Diabetes, Multiparity, and Hyperlipidemia with Preeclampsia
Maternal Factors Linked to Preeclampsia
Keywords:
Gestational Diabetes, Hyperlipidemia, Preeclampsia, Microcytic Anemia, MultiparityAbstract
Background: Preeclampsia is a multifactorial disorder of hypertension and proteinuria, which has a global prevalence of 2-8% of pregnancies. Its pathogenesis is still unclear, and the major risk factors are obesity, nulliparity, and preliminary hypertension. Present study was aimed to analyze associated risk factors and altered levels of hematology and serum lipids in preeclampsia patients.
Methods: This case-control study was conducted at the Institute of Biochemistry, University of Sindh, Jamshoro. The study was carried out from June 2024 to May 2025. Pregnant women, 75 with preeclampsia (Preeclampsia patients) and 75 without preeclamopsia (controls) were included. Blood samples (5 ml) were collected from participants to analyze hematology and lipid profile along with questionnaire. SPSS version 21 was used for statistical analysis, p value <0.05 for level was the level of significance at 95% confidence interval.
Results: The study presents an overview of the comparative analysis of complete blood count, altered serum lipid levels, and associated risk factors including gestational diabetes, multiparity, microcytic anemia, and hyperlipidemia were found among preeclampsia patients. It also highlights major differences in parameters like hemoglobin, RBCs, platelets, monocytes, lymphocytes and monocytes in preeclampsia patients and healthy controls.
Conclusion: Gestational diabetes, multiparity, microcytic anemia, and hyperlipidemia are positively associated with preeclampsia. High salt intake and red meat consumption are also significantly positively associated with preeclampsia disease. What these results show is that preeclampsia isn't caused by just one thing, it's a mixture of factors and that pushes hard for thorough prenatal screening of metabolic problems and blood abnormalities.
References
Chappell LC, Cluver CA, Tong S. Pre-eclampsia. Lancet. 2021;398(10297):341-54.
DOI: https://doi.org/10.1016/S0140-6736(20)32335-7
Mehta LS, Warnes CA, Bradley E, Burton T, Economy K, Mehran R, et al. Cardiovascular considerations in
caring for pregnant patients. Circulation. 2020;141(23):e884-903.
DOI: https://doi.org/10.1161/CIR.0000000000000772
Fox R, Kitt J, Leeson P, Aye CY, Lewandowski AJ. Preeclampsia: risk factors, diagnosis, management. J Clin Med. 2019;8(10):1625.
DOI: https://doi.org/10.3390/jcm8101625
Yang Y, Wu N. Gestational diabetes mellitus and preeclampsia. Front Cardiovasc Med. 2022;9:831297.
DOI: https://doi.org/10.3389/fcvm.2022.831297
Boulton PA, Magliano PD, Boyko PE. IDF Diabetes Atlas 2021. J Diabetes Res. 2021.
DOI: https://doi.org/10.1155/2022/35914061
Vounzoulaki E, et al. Progression to type 2 diabetes after gestational diabetes. BMJ. 2020;13:m1361.
DOI: https://doi.org/10.1136/bmj.m1361
Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and cardiovascular disease risk. Diabetologia.
;62(6):905-14.
DOI: https://doi.org/10.1007/s00125-019-4840-2
Lu Y, Jia Z, Su S, Han L, Meng L, Tang G, et al. Trimester-specific lipid reference intervals. Ann Med.
;53:1632-41.
DOI: https://doi.org/10.1080/07853890.2021.1974082
Khaire AA, Thakar SR, Wagh GN, Joshi SR. Placental lipid metabolism. J Hypertens. 2021;39:127-34.
DOI: https://doi.org/10.1097/HJH.0000000000002596
Poornima IG, Indram M, Ross JD, Agarwala A, Wild RA. Hyperlipidemia and preeclampsia risk. J Clin Lipidol. 2022;16(3):253-60.
DOI: https://doi.org/10.1016/j.jacl.2022.02.005
Alloubani A, Nimer R, Samara R. Hyperlipidemia, CVD, and stroke. Curr Cardiol Rev. 2021;17(6):52-66.
DOI: https://doi.org/10.2174/1573403X16999201210200342
He Y, Huang Z, Wei C, Chen J. GDM, hyperglycemia, pancreatitis case. Front Endocrinol. 2023;14:1220957.
DOI: https://doi.org/10.3389/fendo.2023.1220957
Civeira F, Arca M, Cenarro A, Hegele RA. Hypercholesterolemia definition. J Clin Lipidol.
;16(6):813-21.
DOI: https://doi.org/10.1016/j.jacl.2022.09.006
Mauri M, Calmarza P, Ibarretxe D. Dyslipidemias and pregnancy. Clin Investig Arterioscler. 2021;33(1):41-52.
DOI: https://doi.org/10.1016/j.arteri.2020.10.002
McGinnis R, Steinthorsdottir V, Williams NO, et al. Fetal FLT1 variants and preeclampsia. Nat Genet.
;49(8):1255-60.
DOI: https://doi.org/10.1038/ng.3895
Gibbins JM. Platelets in preeclampsia. J Thromb Haemost. 2023;21(7):1750-2.
DOI: https://doi.org/10.1016/j.jtha.2023.03.031
Gresham E, Byles JE, Mishra GD. Maternal diet and pregnancy outcomes. Public Health Nutr.
;22(7):1346-60.
DOI: https://doi.org/10.1017/S1368980018002616
Jorquera G, Fornes R, Cruz G, Thomas-Valdés S. Polyphenols and preeclampsia. Antioxidants.
;11(11):2294.
DOI: https://doi.org/10.3390/antiox11112294
Pavlidou E, Papadopoulou SK, Alexatou O. Gestational hypertension & Mediterranean diet. Medicina.
;59(12):2103.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Quratulain Soomro, Naseem Aslam Channa, Hunza, Zeeshan Ali Rajput, Zoya Channar, Marvi Sheikh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
